0001437749-24-000480.txt : 20240103
0001437749-24-000480.hdr.sgml : 20240103
20240103193423
ACCESSION NUMBER: 0001437749-24-000480
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tsuchimoto Kim R
CENTRAL INDEX KEY: 0001333516
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 24509194
MAIL ADDRESS:
STREET 1: C/O MONOPAR THERAPEUTICS INC.
STREET 2: 1000 SKOKIE BLVD., SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-12-31
0001645469
Monopar Therapeutics
MNPR
0001333516
Tsuchimoto Kim R
1000 SKOKIE BLVD SUITE 350
WILMETTE
IL
60091
1
1
Chief Financial Officer
0
Common Stock
2023-12-31
4
M
0
9957
A
47943
D
Common Stock
2023-12-31
4
F
0
4073
0.3402
D
43870
D
Common Stock
2024-01-01
4
M
0
1231
A
45101
D
Common Stock
2024-01-01
4
F
0
505
0.3402
D
44596
D
Restricted Stock Units
2023-12-31
4
M
0
9957
0
D
Common Stock
9957
95556
D
Restricted Stock Units
2024-01-01
4
M
0
1231
0
D
Common Stock
1231
94325
D
Represents shares acquired on vesting and settlement of restricted stock units.
Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
On January 31, 2020 the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
/s/ Kim R. Tsuchimoto
2024-01-03